Cargando…
Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
In the last decades, the use of nanocarriers for immunotherapeutic purposes has gained a lot of attention, especially in the field of tumor therapy. However, most types of nanocarriers accumulate strongly in the liver after systemic application. Due to the default tolerance-promoting role of liver n...
Autores principales: | Cacicedo, Maximiliano L., Medina-Montano, Carolina, Kaps, Leonard, Kappel, Cinja, Gehring, Stephan, Bros, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563539/ https://www.ncbi.nlm.nih.gov/pubmed/32872352 http://dx.doi.org/10.3390/cells9091985 |
Ejemplares similares
-
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
por: Kaps, Leonard, et al.
Publicado: (2023) -
Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation
por: Medina-Montano, Carolina, et al.
Publicado: (2022) -
Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells
por: Medina-Montano, Carolina, et al.
Publicado: (2022) -
mRNA-Based Approaches to Treating Liver Diseases
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022) -
Systemically
Administered TLR7/8 Agonist and Antigen-Conjugated
Nanogels Govern Immune Responses against Tumors
por: Stickdorn, Judith, et al.
Publicado: (2022)